Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keybanc Initiates Coverage On Benefitfocus with Overweight Rating, Announces Price Target of $10

Author: Benzinga Newsdesk | September 16, 2022 05:24am
Keybanc analyst Scott Schoenhaus initiates coverage on Benefitfocus (NASDAQ:BNFT) with a Overweight rating and announces Price Target of $10.

Posted In: BNFT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist